Lead Clinical Pharmacist, Oncology Programs

The Lead Oncology Pharmacist is Leap’s accountable clinical owner for oncology, overseeing individual cases and building the clinical standards needed to safely support appropriate patients in the home or an ambulatory infusion center (AIC).

You’ll join an early-stage oncology program, establish its clinical model, and serve as Leap’s clinical counterpart to oncologists and cancer centers. This role reports to the Sr. Director, Clinical Strategy and Affairs and partners closely with Clinical Operations, Manufacturer and Specialty Pharmacy Relations, and Customer Success.

KEY RESPONSIBILITIES

ONCOLOGY CLINICAL PROGRAM OVERSIGHT

• Own and evolve Leap’s oncology clinical model, including patient eligibility, therapy-specific guardrails, lab and treatment-clearance requirements, monitoring, and escalation standards.
• Evaluate oncology therapies for Leap’s Specialty Drug List and define appropriate patients, regimens, and administration settings.
• Maintain alignment with applicable clinical guidelines, professional standards, and FDA labeling.

CASE-LEVEL CLINICAL OVERSIGHT

• Review every oncology case before initiation and reassess as treatment or clinical status changes, considering regimen, prior tolerance, labs, monitoring needs, and patient-specific risks.
• Serve as the oncology clinical escalation point for Care Guides, nurses, and pharmacy partners, coordinating with the treating team when clarification or additional safeguards are needed.
• Define symptom surveillance and adverse-event escalation pathways, including delayed immune-related reactions, and use safety findings to improve care.

PROVIDER CLINICAL ENGAGEMENT

• Lead clinician-to-clinician discussions with oncologists and cancer centers, including complex cases and site-of-care appropriateness.
• Develop provider-facing clinical materials and education that build confidence in Leap's oncology model.
• Build relationships with priority oncology practices and clinical champions.

CLINICAL STANDARDS AND PROGRAM DEVELOPMENT

…